Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 3:01 pm Sale | 2025-06-30 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management LP | 2,140,605 5.970% | -488,924![]() (-18.59%) | Filing History |
| 2025-07-22 5:15 pm Purchase | 2025-06-20 | 13D | BIOMEA FUSION INC BMEA | Cormorant Asset Management LP | 3,681,664 6.460% | 3,681,664![]() (New Position) | Filing History |
| 2025-05-19 5:47 pm Purchase | 2025-03-31 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management LP | 1,849,590 9.990% | 1,849,590![]() (New Position) | Filing History |
| 2025-05-19 3:02 pm Sale | 2025-05-15 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management LP | 0 0.000% | -1,837,739![]() (Position Closed) | Filing History |
| 2025-05-15 3:03 pm Sale | 2025-03-31 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management LP | 0 0.000% | -1,394,336![]() (Position Closed) | Filing History |
| 2025-05-15 3:01 pm Purchase | 2025-03-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management LP | 1,745,000 8.570% | 51,781![]() (+3.06%) | Filing History |
| 2025-05-15 3:00 pm Purchase | 2025-03-31 | 13G | CARGO THERAPEUTICS INC CRGX | Cormorant Asset Management LP | 3,381,277 7.330% | 3,381,277![]() (New Position) | Filing History |
| 2025-02-14 3:03 pm Purchase | 2024-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management LP | 1,693,219 9.080% | 553,219![]() (+48.53%) | Filing History |
| 2025-02-14 3:01 pm Purchase | 2024-12-31 | 13G | KALA BIO, INC. KALA | Cormorant Asset Management LP | 609,027 9.990% | 609,027![]() (New Position) | Filing History |
| 2025-02-14 3:00 pm Purchase | 2024-12-31 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management LP | 2,629,529 7.340% | 2,629,529![]() (New Position) | Filing History |
| 2024-11-14 3:11 pm Purchase | 2024-09-30 | 13G | RAPPORT THERAPEUTICS INC RAPP | Cormorant Asset Management LP | 2,940,921 8.040% | 638![]() (+0.02%) | Filing History |
| 2024-11-14 3:10 pm Purchase | 2024-09-30 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 2,790,462 8.100% | 648,956![]() (+30.30%) | Filing History |
| 2024-11-14 3:10 pm Purchase | 2024-09-30 | 13G | EYEPOINT INC EYPT | Cormorant Asset Management LP | 8,325,000 12.200% | 2,286,765![]() (+37.87%) | Filing History |
| 2024-11-14 3:09 pm Purchase | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management LP | 2,375,000 19.500% | 350,000![]() (+17.28%) | Filing History |
| 2024-11-14 3:08 pm Purchase | 2024-09-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management LP | 1,140,000 4.670% | 506,655![]() (+80.00%) | Filing History |
| 2024-11-14 3:06 pm Sale | 2024-09-30 | 13G | VENTYX BIOSCIENCES INC VTYX | Cormorant Asset Management LP | 0 0.000% | -3,670,000![]() (Position Closed) | Filing History |
| 2024-11-14 3:05 pm Sale | 2024-09-30 | 13G | TSCAN THERAPEUTICS INC TCRX | Cormorant Asset Management LP | 0 0.000% | -2,500,000![]() (Position Closed) | Filing History |
| 2024-11-14 3:05 pm Sale | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 500,000 1.310% | -1,721,422![]() (-77.49%) | Filing History |
| 2024-11-14 3:05 pm Sale | 2024-09-30 | 13G | NEUROGENE INC NGNE | Cormorant Asset Management LP | 107,344 0.830% | -638,836![]() (-85.61%) | Filing History |
| 2024-11-14 3:04 pm Sale | 2024-09-30 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Cormorant Asset Management LP | 0 0.000% | -3,250,000![]() (Position Closed) | Filing History |

